Corrigendum to “Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients”

Table 2

Genotype and allele frequencies of the polymorphisms studied in diabetic patients and controls.

Gene/polymorphism	Genotypes	Diabetes	Controls	OR (95% CI)		of HWE
	Alleles	(%)	(%)
TXNIP; rs7211	CC	345 (55.4)	528 (54.5)	Reference		0.880
	CT	239 (38.4)	376 (38.8)	0.97 (0.78–1.2)	0.798
	TT	39 (6.2)	65 (6.7)	0.92 (0.60–1.39)	0.690
	C	939 (74.6)	1432 (73.9)	Reference
	T	317 (25.4)	506 (26.1)	0.966 (1.82–1.37)	0.674
NQO1; rs1800566	CC	216 (34.7)	327 (33)	Reference		0.406
	CT	288 (46.2)	483 (48.6)	0.90 (0.7–1.1)	0.373
	TT	119 (19.1)	183 (18.4)	0.98 (0.7–1.3)	0.915
	C	720 (57.8)	1137 (57.25)	Reference
	T	526 (42.2)	849 (42.75)	0.98 (0.85–1.13)	0.765
HMOX-1; rs2071749	AA	269 (43.8)	413 (43.2)	Reference		0.625
	AG	267 (43.5)	417 (43.6)	0.98 (0.79–1.2)	0.877
	GG	78 (12.7)	126 (13.2)	0.95 (0.69–1.3)	0.757
	A	805 (65.5)	1243 (65)	Reference
	G	423 (34.5)	669 (35)	0.97 (0.84–1.13)	0.755
NRF2; rs2364723	CC	210 (33.6)	301 (30.3)	Reference		0.092
	CG	286 (45.7)	471 (47.5)	0.87 (0.7–1.1)	0.236
	GG	129 (20.6)	220 (22.2)	0.84 (0.63–1.1)	0.223
	C	706 (56.5)	1073 (54)	Reference
	G	544 (43.5)	911 (46)	0.91 (0.79–1.05)	0.182
NRF2; rs6721961	CC	407 (65.3)	618 (62.5)	Reference		0.281
	CA	189 (30.4)	317 (32)	0.90 (0.7–1.1)	0.374
	AA	27 (4.3)	54 (5.5)	0.76 (0.5–1.2)	0.259
	C	1003 (80.5)	1553 (78.5)	Reference
	A	243 (19.5)	425 (21.5)	0.88 (0.74–1.05)	0.176

CI, confidence interval; HWE, Hardy-Weinberg equilibrium; HMOX-1, heme oxygenase 1; NQO1, NAD(P)H quinone oxidoreductase 1; NRF2, nuclear factor-erythroid 2- (NF-E2-) related factor 2; OR, odds ratio; and TXNIP, thioredoxin-interacting protein.